Atrial fibrillation (AF) is one of the most common sustained cardiac arrhythmias and its prevalence is increasing worldwide in line with the growing elderly population. Many single nucleotide polymorphisms and mutations are associated with AF, including the common loss-of-function histidine-558-to-arginine (H558R) polymorphism of the human cardiac sodium channel, voltage-gated, type V, α subunit (encoded by the SCN5A gene). The H558R polymorphism results from the T-C transition in the SCN5A gene. This study recruited 135 patients with AF and 296 healthy controls to scan for and perform targeted genotyping of the H558R polymorphism of the SCN5A gene. Logistic regression analysis showed that the TC and CC genotypes (i.e. genotypes that result in the R558 polymorphism) were significantly associated with an increased risk of developing AF. The R558 polymorphism conferred an odds ratio for AF of 3.451 (95% confidence interval 1.718, 6.931). In conclusion, this study provided evidence for the role of the H558R polymorphism of the SCN5A gene in increasing the susceptibility to AF.
GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults. national implications for rhythm management and stroke prevention. the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA2001; 285: 2370–2375.
2.
WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke. the Framingham Study. Stroke1991; 22: 983–988.
3.
BenjaminEJWolfPAD'AgostinoRBImpact of atrial fibrillation on the risk of death. the Framingham Heart Study. Circulation1998; 98: 946–952.
4.
BenjaminEJLevyDVaziriSMIndependent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA1994; 271: 840–844.
5.
ChenLYBallewJDHerronKJA common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther2007; 81: 35–41.
6.
LaiLPSuMJYehHMAssociation of the human minK gene 38G allele with atrial fibrillation. evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J2002; 144: 485–490.
7.
SchreieckJDostalSvon BeckerathNC825T polymorphism of the G-protein β3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J2004; 148: 545–550.
8.
TsaiCTLaiLPLinJL: Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation2004; 109: 1640–1646.
9.
RavnLSHofman-BangJDixenU: Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am J Cardiol2005; 96: 405–407.
10.
BrugadaRTapscottTCzernuszewiczGZ: Identification of a genetic locus for familial atrial fibrillation. N Engl J Med1997; 336: 905–911.
11.
EllinorPTShinJTMooreRK: Locus for atrial fibrillation maps to chromosome 6q14–16. Circulation2003; 107: 2880–2883.
12.
DarbarDHardyAHainesJL: Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol2008; 51: 1083–1089.
13.
YangYXiaMJinQ: Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet2004; 75: 899–905.
14.
XiaMJinQBendahhouS: A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun2005; 332: 1012–1019.
15.
OlsonTMAlekseevAELiuXK: Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet2006; 15: 2185–2191.
16.
HuDSunY: Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol2008; 52: 865–868.
17.
ShiLLiCWangC: Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet2009; 126: 843–849.
18.
RobertsJDGollobMH: Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol2010; 55: 705–712.
19.
GellensMEGeorgeALJrChenLQ: Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A1992; 89: 554–558.
GeorgeALJrVarkonyTADrabkinHA: Assignment of the human heart tetrodotoxin-resistant voltage-gated Na+ channel α-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet1995; 68: 67–70.
22.
ChenQKirschGEZhangD: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature1998; 392: 293–296.
23.
Laitinen-ForsblomPJMäkynenPMäkynenH: SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias. J Cardiovasc Electrophysiol2006; 17: 480–485.
24.
BensonDWWangDWDymentM: Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest2003; 112: 1019–1028.
25.
AkaiJMakitaNSakuradaH: A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett2000; 479: 29–34.
26.
SchottJJAlshinawiCKyndtF: Cardiac conduction defects associate with mutations in SCN5A. Nat Genet1999; 23: 20–21.
27.
LiuKYangTViswanathanPC: New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant. Circulation2005; 112: 3239–3246.
28.
SplawskiITimothyKWTateyamaM: Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science2002; 297: 1333–1336.
29.
ViswanathanPCBensonDWBalserJR: A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest2003; 111: 341–346.
30.
YeBValdiviaCRAckermanMJ: A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics2003; 12: 187–193.
31.
PoelzingSForleoCSamodellM: SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation2006; 114: 368–376.
32.
ChenJZXieXDWangXX: Single nucleotide polymorphisms of the SCN5A gene in Han Chinese and their relation with Brugada syndrome. Chin Med J (Engl)2004; 117: 652–656.
33.
LizotteEJunttilaMJDubeMP: Genetic modulation of Brugada syndrome by a common polymorphism. J Cardiovasc Electrophysiol2009; 20: 1137–1141.
34.
MarangoniSDi RestaCRocchettiM: A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization. Cardiovasc Res2011; 91: 606–616.
35.
SmitsJPKoopmannTTWildersR: A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol2005; 38: 969–981.
36.
WangQShenJSplawskiI: SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell1995; 80: 805–811.
37.
MakiyamaTAkaoMShizutaS: A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol2008; 52: 1326–1334.
38.
AminASTanHLWildeAA: Cardiac ion channels in health and disease. Heart Rhythm2010; 7: 117–126.
39.
BrugadaPBrugadaJ: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol1992; 20: 1391–1396.
40.
HedleyPLJorgensenPSchlamowitzS: The genetic basis of Brugada syndrome: A mutation update. Hum Mutat2009; 30: 1256–1266.
41.
GussakIAntzelevitchCBjerregaardP: The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol1999; 33: 5–15.
42.
KyndtFProbstVPotetF: Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation2001; 104: 3081–3086.
43.
OlsonTMMichelsVVBallewJD: Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA2005; 293: 447–454.
44.
McNairWPKuLTaylorMR: SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation2004; 110: 2163–2167.
45.
AntzelevitchCBrugadaPBorggrefeM: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation2005; 111: 659–670.
46.
NellensPGursoySAndriesE: Transcoronary chemical ablation of arrhythmias. Pacing Clin Electrophysiol1992; 15: 1368–1373.
47.
TanHLKupershmidtSZhangR: A calcium sensor in the sodium channel modulates cardiac excitability. Nature2002; 415: 442–447.
48.
MoritaHKusano-FukushimaKNagaseS: Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol2002; 40: 1437–1444.
49.
WangDWViswanathanPCBalserJR: Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation2002; 105: 341–346.
50.
MakielskiJCYeBValdiviaCR: A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res2003; 93: 821–828.
